Subcutaneous Amivantamab for NSCLC Could Benefit Patients, Practices: Balazs Halmos, MD | AJMC
Subcutaneous Amivantamab for NSCLC Could Benefit Patients, Pr…
5 months ago
ajmc.com
FDA Approval of Subcutaneous Amivantamab Is Significant Step Forward in NSCLC: Martin Dietrich, MD, PhD | AJMC
FDA Approval of Subcutaneous Amivantamab Is Significant Step F…
3 months ago
ajmc.com
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory EGFR-Mutated, Advanced Non-Small Cell Lung Cancer (NSCLC): Primary Results, Including Overall Survival (OS), From the Global, Phase 3, Randomized Controlled PALOMA-3 Trial | OncLive
8:58
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both i…
Jun 25, 2024
onclive.com
Amivantamab Accolades Add Up for NSCLC | AJMC
3:48
Amivantamab Accolades Add Up for NSCLC | AJMC
Sep 27, 2024
ajmc.com
ESMO 2025 Insights: Amivantamab in Recurrent/Metastatic HNSCC After Progression on Checkpoint Inhibition and Chemo - OrigAMI-4 Study Results
ESMO 2025 Insights: Amivantamab in Recurrent/Metastatic HNSCC Af…
4 months ago
vumedi.com
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC) With Biomarkers of High-Risk Disease: A Secondary Analysis From the Phase 3 MARIPOSA Study | OncLive
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mu…
Jun 19, 2024
onclive.com
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: Amivantamab & Lazertinib Data
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: …
275 viewsJul 19, 2021
vumedi.com
PAPILLON Study - Amivantamab Chemo vs. Chemo as 1L Treatmen…
854 viewsNov 17, 2023
vumedi.com
Dr Joshua Sabari Discusses Amivantamab’s First-Line Approv…
Mar 4, 2024
ajmc.com
3:38
Updates from PAPILLON: 1L Amivantamab Chemotherapy in A…
Nov 14, 2023
targetedonc.com
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
Nov 14, 2023
targetedonc.com
Adverse Event Management Strategies for Amivantamab-Base…
Feb 19, 2025
onclive.com
Amivantamab Toxicity Mitigation Strategies in the Treatment of EGF…
11 months ago
onclive.com
Dr Pietrantonio on Future Directions of Evaluating Amivantamab in CR…
1 year ago
onclive.com
Dr Leighl on Amivantamab in Advanced NSCLC With MET Exon …
Sep 12, 2023
onclive.com
13:44
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Tre…
Nov 30, 2023
onclive.com
Dr Girard on the Efficacy of First-Line Amivantamab Plus Chemothe…
1 month ago
onclive.com
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
Dr Arnold on the Evaluation of Chemo With Amivantamab or Cetu…
9 months ago
onclive.com
0:07
📣 The U.S. Food and Drug Administration has approved a ne…
259 views3 months ago
FacebookGO2 for Lung Cancer
3:01
About Advanced (Metastatic) Prostate Cancer
72.2K viewsNov 9, 2020
YouTubeMacmillan Cancer Support
4:06
How and Why Prostate Cancer Treatment Affects Men’s Lives
6K viewsJan 24, 2019
YouTubeMayo Clinic
5:14
Olaparib and Keytruda For Advanced Prostate Cancer | | Lear…
3.6K viewsJan 8, 2020
YouTubeProstate Cancer Research Institute
2:38
First-Line Carboplatin and Pemetrexed With Pembrolizumab f…
5K viewsJun 20, 2017
YouTubeTargeted Oncology
7:59
Radiation therapy for prostate can…
HIGHLY RANKED HOSPITAL
About this channel
YouTubeSunnybrook Hospital
5:15
Rucaparib and Olaparib: Two New Treatments Approved for Advance…
4K viewsJun 2, 2020
YouTubeProstate Cancer Research Institute
7:39
High PSA & Prostatitis | Ask a Prostate Expert, Mark Scholz, MD
101.4K viewsSep 9, 2020
YouTubeProstate Cancer Research Institute
3:12
Adverse Effects of Hormone Therapy in Prostate Cancer
47.8K viewsApr 2, 2019
YouTubeOncLive
4:40
Activating the Immune System to Fight Prostate Cancer: Andy's Im…
67.2K viewsJun 23, 2017
YouTubeCancer Research Institute
6:43
Does Sugar Feed Prostate Cancer? Does Fatty/Adipose Tissue Attrac…
175.8K viewsJan 10, 2021
YouTubeProstate Cancer Research Institute
See more videos
Static thumbnail place holder